Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

hands type on keyboard and search for rare disease zebra

Maximizing Consumer Engagement with People Living with Rare Disease

August 2, 2023

Understanding the difficulties people with rare conditions often face can help set the table for the engagement challenges pharma marketers typically face.

Social Health Network's 2023 Social Health Awards winners.

Introducing the 2023 Social Health Awards Winners

July 26, 2023

Meet the groundbreaking group of 2023 award winners who you can connect with through Health Union's Social Health Network!

What Is HCP Targeting?

May 14, 2023

With advanced HCP targeting, you can focus your ad spend on a more cultivated target list of HCPs.

Rare Conditions: The Impact of Mental Health Concerns

April 24, 2023

More than half of NMOSD In America 2022 respondents said being diagnosed with NMOSD has negatively impacted their mental health.

IBS Patient-Reported Survey Data 2020

October 19, 2020

Merely 9% of people living with IBS were currently taking a prescription IBS medication, according to new Health Union patient-reported survey data.

Alzheimer’s Disease Patient-Reported Survey Data | 2020

October 6, 2020

Only 11% of people living with Alzheimer’s disease feel controlled on their current treatment plan, according to Health Union patient-reported survey data.

COPD Patient-Reported Survey Data | 2020

September 23, 2020

44% of people living with COPD who experience pain consider themselves as having chronic pain, according to new Health Union survey data.

Multiple Sclerosis Patient-Reported Survey Data | 2020

September 10, 2020

71% of people living with multiple sclerosis currently use a DMT but many live with pain and emotional grief, according to new Health Union survey data.

Healthcare Industry Thought Leadership

Contact